Omvoh (mirikizumab) — A Lilly Medicine

What's New? Watch Now.

Learn more about how Omvoh can help your UC patients with their most burdensome symptom.

Prof. Jimmy Limdi

Prof. Jimmy Limdi Reviews 4years Long-Term Remission With OMVOH

Dr. Alissa Walsh

Dr. Alissa: Patient Case of Moderately to Severely Active UC

Prof. Sebastian Zeissig

Bio-naïve Ulcerative Colitis patient treated with Omvoh

Prof. Sebastian Zeissig

Prof. Sebastian Zeissig: Bio-failed UC Patient Returns To Normalcy

Prof. Axel Dignass

Setting New Standards in Long-Term Remission with Mirikizumab

Dr. Tim Raine

LUCENT-1 & LUCENT-2 Trials with Dr Tim Raine

Prof. Vipul Jairath

Results from the VIVID-1 Study: Prof. Vipul Jairath

Prof. Marc Ferrante

The Challenge Of Recurring Symptoms

Dr. Alissa Walsh

Results From VIVID-1 with Dr. Alissa Walsh

Prof. Marc Ferrante

Results from the VIVID-2 Extension Study: Long-Term Efficacy & Safety

Dr. Alissa Walsh

Key Takeaways From VIVID-1 with Dr. Alissa Walsh

Prof. Jimmy Limdi

Prof. Jimmy Limdi: 4Year Long Term Remission with Omvoh